Lilly to invest $6 billion in Huntsville manufacturing hub
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
Max and Luna personify HRV Pharma’s core values of trust, loyalty, and authentic partnership
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Subscribe To Our Newsletter & Stay Updated